{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T12:33:47Z","timestamp":1792154027164,"version":"4.4.0"},"reference-count":56,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T00:00:00Z","timestamp":1776816000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100002429","name":"Amgen Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002429","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["kidney-international.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.kint.2026.03.018","type":"journal-article","created":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T23:53:10Z","timestamp":1777161190000},"page":"400-412","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["The calcimimetic etelcalcetide restores cardiac function in chronic hyperphosphatemia via calcium sensing receptor\u2013cAMP activation"],"prefix":"10.1016","volume":"110","author":[{"given":"Andrea","family":"Grund","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Manegold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gloria Sophie","family":"Richter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatrice","family":"Richter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Thiele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise H.","family":"Baer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathrin","family":"Kowalski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresia","family":"Kraft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Thum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix A.","family":"Trogisch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f6rg","family":"Heineke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dieter","family":"Haffner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9203-7622","authenticated-orcid":false,"given":"Maren","family":"Leifheit-Nestler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.kint.2026.03.018_bib1","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1016\/j.jacc.2022.11.005","article-title":"The global burden of cardiovascular diseases and risk: a compass for future health","volume":"80","author":"Vaduganathan","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.kint.2026.03.018_bib2","doi-asserted-by":"crossref","first-page":"320","DOI":"10.3945\/ajcn.113.073148","article-title":"High dietary phosphorus intake is associated with all-cause mortality: results from NHANES III","volume":"99","author":"Chang","year":"2014","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.kint.2026.03.018_bib3","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/3162806","article-title":"Phosphate and cardiovascular disease beyond chronic kidney disease and vascular calcification","volume":"2018","author":"Disthabanchong","year":"2018","journal-title":"Int J Nephrol"},{"key":"10.1016\/j.kint.2026.03.018_bib4","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/ki.2012.303","article-title":"Dietary phosphorus is associated with greater left ventricular mass","volume":"83","author":"Yamamoto","year":"2013","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2026.03.018_bib5","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.atherosclerosis.2013.12.051","article-title":"Serum phosphate is associated with aortic valve calcification in the Multi-ethnic Study of Atherosclerosis (MESA)","volume":"233","author":"Linefsky","year":"2014","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.kint.2026.03.018_bib6","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1681\/ASN.2007070760","article-title":"The mechanism of phosphorus as a cardiovascular risk factor in CKD","volume":"19","author":"Mathew","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2026.03.018_bib7","doi-asserted-by":"crossref","first-page":"609","DOI":"10.2215\/CJN.04100808","article-title":"Serum phosphorus concentrations and arterial stiffness among individuals with normal kidney function to moderate kidney disease in MESA","volume":"4","author":"Ix","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2026.03.018_bib8","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1038\/ki.2013.213","article-title":"Phosphate restriction significantly reduces mortality in uremic rats with established vascular calcification","volume":"84","author":"Finch","year":"2013","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2026.03.018_bib9","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1093\/cvr\/cvs240","article-title":"Effects of phosphate on vascular function under normal conditions and influence of the uraemic state","volume":"96","author":"Six","year":"2012","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.kint.2026.03.018_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(15)60325-7","article-title":"Phosphate as a cardiovascular risk factor: effects on vascular and endothelial function","volume":"385","author":"Stevens","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.kint.2026.03.018_bib11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0074996","article-title":"Serum phosphate as a risk factor for cardiovascular events in people with and without chronic kidney disease: a large community based cohort study","volume":"8","author":"McGovern","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.kint.2026.03.018_bib12","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1681\/ASN.2010121224","article-title":"FGF-23 associates with death, cardiovascular events, and initiation of chronic dialysis","volume":"22","author":"Kendrick","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2026.03.018_bib13","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.2215\/CJN.11901115","article-title":"Phosphate toxicity in CKD: the killer among us","volume":"11","author":"Ritter","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2026.03.018_bib14","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1681\/ASN.2008040349","article-title":"Association of serum phosphate with vascular and valvular calcification in moderate CKD","volume":"20","author":"Adeney","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2026.03.018_bib15","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1681\/ASN.2006121385","article-title":"Role of hyperphosphatemia and 1,25-dihydroxyvitamin D in vascular calcification and mortality in fibroblastic growth factor 23 null mice","volume":"18","author":"Stubbs","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2026.03.018_bib16","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1681\/ASN.2014050465","article-title":"Klotho and phosphate are modulators of pathologic uremic cardiac remodeling","volume":"26","author":"Hu","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2026.03.018_bib17","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1038\/s41598-017-02068-6","article-title":"FGF23\/FGFR4-mediated left ventricular hypertrophy is reversible","volume":"7","author":"Grabner","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.kint.2026.03.018_bib18","doi-asserted-by":"crossref","first-page":"4393","DOI":"10.1172\/JCI46122","article-title":"FGF23 induces left ventricular hypertrophy","volume":"121","author":"Faul","year":"2011","journal-title":"J Clin Invest"},{"key":"10.1016\/j.kint.2026.03.018_bib19","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/j.cmet.2015.09.002","article-title":"Activation of cardiac fibroblast growth factor receptor 4 causes left ventricular hypertrophy","volume":"22","author":"Grabner","year":"2015","journal-title":"Cell Metab"},{"key":"10.1016\/j.kint.2026.03.018_bib20","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1161\/CIRCULATIONAHA.114.013876","article-title":"Cinacalcet, fibroblast growth factor-23, and cardiovascular disease in hemodialysis: the Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) trial","volume":"132","author":"Moe","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.kint.2026.03.018_bib21","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1001\/jama.2016.19468","article-title":"Effect of etelcalcetide vs cinacalcet on serum parathyroid hormone in patients receiving hemodialysis with secondary hyperparathyroidism: a randomized clinical trial","volume":"317","author":"Block","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.kint.2026.03.018_bib22","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1161\/CIRCRESAHA.120.318556","article-title":"Randomized trial of etelcalcetide for cardiac hypertrophy in hemodialysis","volume":"128","author":"D\u00f6rr","year":"2021","journal-title":"Circ Res"},{"key":"10.1016\/j.kint.2026.03.018_bib23","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1093\/ndt\/gfad043","article-title":"Parathyroidectomy versus oral cinacalcet on cardiovascular parameters in peritoneal dialysis patients with advanced secondary hyperparathyroidism (PROCEED): a randomized trial","volume":"38","author":"Wang","year":"2023","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2026.03.018_bib24","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1093\/ckj\/sfx125","article-title":"Old and new calcimimetics for treatment of secondary hyperparathyroidism: impact on biochemical and relevant clinical outcomes","volume":"11","author":"Pereira","year":"2018","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.kint.2026.03.018_bib25","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1038\/ki.2014.215","article-title":"Parathyroid hormone activates the orphan nuclear receptor Nurr1 to induce FGF23 transcription","volume":"86","author":"Meir","year":"2014","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2026.03.018_bib26","doi-asserted-by":"crossref","first-page":"4693","DOI":"10.1038\/s41467-019-12399-9","article-title":"Phosphate acts directly on the calcium-sensing receptor to stimulate parathyroid hormone secretion","volume":"10","author":"Centeno","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.kint.2026.03.018_bib27","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/s41586-021-03691-0","article-title":"Asymmetric activation of the calcium-sensing receptor homodimer","volume":"595","author":"Gao","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.kint.2026.03.018_bib28","doi-asserted-by":"crossref","first-page":"647","DOI":"10.3390\/toxins11110647","article-title":"FGF23 and phosphate-cardiovascular toxins in CKD","volume":"11","author":"Vogt","year":"2019","journal-title":"Toxins (Basel)"},{"key":"10.1016\/j.kint.2026.03.018_bib29","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1161\/ATVBAHA.123.319198","article-title":"Phosphate in cardiovascular disease: from new insights into molecular mechanisms to clinical implications","volume":"44","author":"Turner","year":"2024","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.kint.2026.03.018_bib30","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1681\/ASN.2004060512","article-title":"Cinacalcet HCl, an oral calcimimetic agent for the treatment of secondary hyperparathyroidism in hemodialysis and peritoneal dialysis: a randomized, double-blind, multicenter study","volume":"16","author":"Lindberg","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2026.03.018_bib31","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1159\/000435838","article-title":"Left ventricular hypertrophy in chronic kidney disease patients: from pathophysiology to treatment","volume":"5","author":"Di Lullo","year":"2015","journal-title":"Cardiorenal Med"},{"key":"10.1016\/j.kint.2026.03.018_bib32","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1681\/ASN.V5122024","article-title":"The prognostic importance of left ventricular geometry in uremic cardiomyopathy","volume":"5","author":"Foley","year":"1995","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2026.03.018_bib33","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1093\/ndt\/11.7.1277","article-title":"Outcome and risk factors for left ventricular disorders in chronic uraemia","volume":"11","author":"Parfrey","year":"1996","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2026.03.018_bib34","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1681\/ASN.V1251079","article-title":"Left ventricular hypertrophy in the renal patient","volume":"12","author":"Middleton","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2026.03.018_bib35","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/937398","article-title":"Heart failure in patients with chronic kidney disease: a systematic integrative review","volume":"2014","author":"Segall","year":"2014","journal-title":"BioMed Research Int"},{"key":"10.1016\/j.kint.2026.03.018_bib36","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1007\/s00467-013-2515-7","article-title":"Associations between fibroblast growth factor 23 and cardiac characteristics in pediatric heart failure","volume":"28","author":"Isakova","year":"2013","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.kint.2026.03.018_bib37","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.745892","article-title":"Cardiac fibroblast growth factor 23 excess does not induce left ventricular hypertrophy in healthy mice","volume":"9","author":"Leifheit-Nestler","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.kint.2026.03.018_bib38","doi-asserted-by":"crossref","DOI":"10.1210\/jendso\/bvab066","article-title":"High FGF23 levels failed to predict cardiac hypertrophy in animal models of hyperphosphatemia and chronic renal failure","volume":"5","author":"Moench","year":"2021","journal-title":"J Endocr Soc"},{"key":"10.1016\/j.kint.2026.03.018_bib39","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.kint.2018.03.024","article-title":"FGF23 effects on the heart-levels, time, source, and context matter","volume":"94","author":"Faul","year":"2018","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2026.03.018_bib40","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1093\/ckj\/sfz034","article-title":"Effects of etelcalcetide on fibroblast growth factor 23 in patients with secondary hyperparathyroidism receiving hemodialysis","volume":"13","author":"Wolf","year":"2020","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.kint.2026.03.018_bib41","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1002\/jcph.1090","article-title":"Clinical pharmacokinetics and pharmacodynamics of etelcalcetide, a novel calcimimetic for treatment of secondary hyperparathyroidism in patients with chronic kidney disease on hemodialysis","volume":"58","author":"Wu","year":"2018","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.kint.2026.03.018_bib42","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1152\/physrev.00054.2009","article-title":"Mitogen-activated protein kinase signaling in the heart: angels versus demons in a heart-breaking tale","volume":"90","author":"Rose","year":"2010","journal-title":"Physiol Rev"},{"key":"10.1016\/j.kint.2026.03.018_bib43","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a022293","article-title":"TGF-\u03b21 signaling and tissue fibrosis","volume":"10","author":"Kim","year":"2018","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"10.1016\/j.kint.2026.03.018_bib44","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.afos.2023.11.002","article-title":"Teriparatide and etelcalcetide improve bone, fibrosis, and fat parameters in chronic kidney disease model rats","volume":"9","author":"Igarashi","year":"2023","journal-title":"Osteoporos Sarcopenia"},{"key":"10.1016\/j.kint.2026.03.018_bib45","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1161\/01.RES.75.3.401","article-title":"Targeted ablation of the phospholamban gene is associated with markedly enhanced myocardial contractility and loss of beta-agonist stimulation","volume":"75","author":"Luo","year":"1994","journal-title":"Circ Res"},{"key":"10.1016\/j.kint.2026.03.018_bib46","doi-asserted-by":"crossref","first-page":"H1544","DOI":"10.1152\/ajpheart.00341.2018","article-title":"Exacerbation of dystrophic cardiomyopathy by phospholamban deficiency mediated chronically increased cardiac Ca2+ cycling in vivo","volume":"315","author":"Law","year":"2018","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.kint.2026.03.018_bib47","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202013074","article-title":"Impairment of the ER\/mitochondria compartment in human cardiomyocytes with PLN p.Arg14del mutation","volume":"13","author":"Cuello","year":"2021","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.kint.2026.03.018_bib48","doi-asserted-by":"crossref","DOI":"10.1172\/JCI17892","article-title":"Human phospholamban null results in lethal dilated cardiomyopathy revealing a critical difference between mouse and human","volume":"111","author":"Haghighi","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1016\/j.kint.2026.03.018_bib49","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/j.ahj.2011.07.028","article-title":"Mutations in the human phospholamban gene in patients with heart failure","volume":"162","author":"Medeiros","year":"2011","journal-title":"Am Heart J"},{"key":"10.1016\/j.kint.2026.03.018_bib50","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1126\/science.1081578","article-title":"Dilated cardiomyopathy and heart failure caused by a mutation in phospholamban","volume":"299","author":"Schmitt","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.kint.2026.03.018_bib51","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2023.1154374","article-title":"Inhibition of the calcium-sensing receptor by extracellular phosphate ions and by intracellular phosphorylation","volume":"14","author":"Centeno","year":"2023","journal-title":"Front Physiol"},{"key":"10.1016\/j.kint.2026.03.018_bib52","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1124\/pr.119.018531","article-title":"International Union of Basic and Clinical Pharmacology, CVIII: calcium-sensing receptor nomenclature, pharmacology, and function","volume":"72","author":"Leach","year":"2020","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.kint.2026.03.018_bib53","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.bone.2017.08.026","article-title":"Etelcalcetide (AMG 416), a peptide agonist of the calcium-sensing receptor, preserved cortical bone structure and bone strength in subtotal nephrectomized rats with established secondary hyperparathyroidism","volume":"105","author":"Li","year":"2017","journal-title":"Bone"},{"key":"10.1016\/j.kint.2026.03.018_bib54","doi-asserted-by":"crossref","first-page":"24435","DOI":"10.1074\/jbc.M801738200","article-title":"Switching of G-protein usage by the calcium-sensing receptor reverses its effect on parathyroid hormone-related protein secretion in normal versus malignant breast cells","volume":"283","author":"Mamillapalli","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1016\/j.kint.2026.03.018_bib55","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1677\/JOE-09-0183","article-title":"The calcium-sensing receptor couples to Galpha(s) and regulates PTHrP and ACTH secretion in pituitary cells","volume":"204","author":"Mamillapalli","year":"2010","journal-title":"J Endocrinol"},{"key":"10.1016\/j.kint.2026.03.018_bib56","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1530\/JME-21-0058","article-title":"Heterogeneity of G protein activation by the calcium-sensing receptor","volume":"67","author":"Abid","year":"2021","journal-title":"J Mol Endocrinol"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S008525382600308X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S008525382600308X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T09:58:16Z","timestamp":1784541496000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S008525382600308X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":56,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S008525382600308X"],"URL":"https:\/\/doi.org\/10.1016\/j.kint.2026.03.018","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The calcimimetic etelcalcetide restores cardiac function in chronic hyperphosphatemia via calcium sensing receptor\u2013cAMP activation","name":"articletitle","label":"Article Title"},{"value":"Kidney International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.kint.2026.03.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of the International Society of Nephrology.","name":"copyright","label":"Copyright"}]}}